Callan Family Office’s Sabra Healthcare REIT SBRA Stock Holding History
Bought
Maintained
Sold
Other funds holding SBRA
CIM
Callan Family Office's SBRA Position: Q2 2026 in Review
Callan Family Office reduced its Sabra Healthcare REIT (SBRA) stake by 27% in Q2 2026, selling an estimated $86.2K and leaving 11,581 shares worth $226K. The position accounts for ﹤0.01% of the portfolio, ranked #1096.
Callan Family Office first reported a position in SBRA in Q4 2025 and has held it in 3 quarters since. The position peaked at $306K in Q1 2026. 466 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.
- Callan Family Office held 11,581 shares of Sabra Healthcare REIT worth $226K as of Q2 2026.
- Callan Family Office sold 4,343 Sabra Healthcare REIT shares in Q2 2026, an estimated $86.2K.
- Sabra Healthcare REIT made up ﹤0.01% of Callan Family Office's portfolio in Q2 2026, its #1096 holding.
- Callan Family Office first reported a position in Sabra Healthcare REIT in Q4 2025 and has held it in 3 quarters since.
- Callan Family Office's Sabra Healthcare REIT position peaked at $306K in Q1 2026.
- 466 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.
Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.